1-223616112-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001143962.2(CAPN8):c.1169G>A(p.Arg390His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,551,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001143962.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN8 | NM_001143962.2 | c.1169G>A | p.Arg390His | missense_variant | 10/21 | ENST00000366872.10 | NP_001137434.1 | |
CAPN8 | XM_017001265.2 | c.686G>A | p.Arg229His | missense_variant | 7/18 | XP_016856754.1 | ||
CAPN8 | XM_017001266.2 | c.488G>A | p.Arg163His | missense_variant | 5/16 | XP_016856755.1 | ||
CAPN8 | XM_017001267.3 | c.1335G>A | p.Pro445Pro | synonymous_variant | 11/11 | XP_016856756.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN8 | ENST00000366872.10 | c.1169G>A | p.Arg390His | missense_variant | 10/21 | 1 | NM_001143962.2 | ENSP00000355837.6 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152280Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000766 AC: 12AN: 156696Hom.: 0 AF XY: 0.0000844 AC XY: 7AN XY: 82906
GnomAD4 exome AF: 0.0000364 AC: 51AN: 1399368Hom.: 0 Cov.: 31 AF XY: 0.0000464 AC XY: 32AN XY: 690170
GnomAD4 genome AF: 0.000151 AC: 23AN: 152398Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74534
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at